April 4 (Reuters) - Cynapsus Therapeutics Inc CTH.TO :
* Cynapsus Therapeutics and Monosol RX announce global IP
licensing agreement
* Signed a global licensing agreement for certain
intellectual property with Monosol RX
* Under agreement, Monosol RX will receive up front and
contingent milestone payments, single-digit royalty payments on
net sales of apl-130277
Source text for Eikon:
Further company coverage: CTH.TO
(Bengaluru Newsroom: +1-646-223-8780)